+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

The effects of the level of ampicillin resistance and the inoculum size on the in-vitro bactericidal activity of the combination of ampicillin and ciprofloxacin against high-level gentamicin-resistant strains of Enterococcus faecium



The effects of the level of ampicillin resistance and the inoculum size on the in-vitro bactericidal activity of the combination of ampicillin and ciprofloxacin against high-level gentamicin-resistant strains of Enterococcus faecium



Journal of Antimicrobial ChemoTherapy 44(5): 719-720




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 011502654

Download citation: RISBibTeXText

PMID: 10552994

DOI: 10.1093/jac/44.5.719


Related references

In-vitro activity of combined ampicillin and ciprofloxacin against high-level gentamicin-resistant strains of Enterococcus faecium: influence of the medium on susceptibility test results. Journal of Antimicrobial ChemoTherapy 41(1): 139-140, 1998

In-vitro activity of combined ampicillin and ciprofloxacin against high- level gentamicin-resistant strains of Enterococcus faecium: influence of the medium on susceptibility test results. Journal of Antimicrobial Chemotherapy 41(1): 139-140, 1998

In vitro activity of the combination of ampicillin and arbekacin against beta-lactam-, glycopeptide-, and high-level gentamicin-resistant Enterococcus faecium. Abstracts of the Interscience Conference on Antimicrobial Agents and Chemotherapy 40: 170-171, 2000

In-vitro synergistic activity of the combination of ampicillin and arbekacin against vancomycin-and high-level gentamicin-resistant Enterococcus faecium with the aph(2")-Id gene. Diagnostic Microbiology and Infectious Disease 37(4): 297-299, 2000

Inconsistent bactericidal activity of triple-combination therapy with vancomycin, ampicillin, and gentamicin against vancomycin-resistant, highly ampicillin-resistant Enterococcus faecium. Antimicrobial Agents and ChemoTherapy 36(7): 1563-1566, 1992

Enterococcus faecium with high-level resistance to gentamicin and ampicillin: an emerging clinical problem. Journal of Antimicrobial ChemoTherapy 34(5): 846-847, 1994

Combinations of ampicillin, fosfomycin, and arbekacin against beta-lactam-, glycopeptide-, and high-level gentamicin-resistant enterococcus faecium. Journal of Antimicrobial ChemoTherapy 44(Suppl. A): 155, 1999

The bactericidal activity of ampicillin, daptomycin, and vancomycin against ampicillin-resistant Enterococcus faecium. Diagnostic Microbiology and Infectious Disease 14(2): 141-145, 1991

Incidence and detection of high level resistance hlr to aminoglycosides in ampicillin resistant enterococcus faecium. Abstracts of the General Meeting of the American Society for Microbiology 92: 463, 1992

In-vitro activity of the combination of ampicillin and arbekacin against high-level gentamicin-resistant enterococci. Journal of Antimicrobial ChemoTherapy 42(6): 836-838, 1998

Simple combined agar-strip test for detection of enterococcal susceptibility to ampicillin, moderate- or high-level gentamicin resistance and potential additive activity of ampicillin plus gentamicin. ChemoTherapy 39(2): 82-87, 1993

Comparison of inhibitory and bactericidal activities and postantibiotic effects of LY333328 and ampicillin used singly and in combination against vancomycin-resistant Enterococcus faecium. Antimicrobial Agents and ChemoTherapy 42(10): 2564-2568, 1998

Comparison of Inhibitory and Bactericidal Activities and Postantibiotic Effects of Ly333328 and Ampicillin Used Singly and in Combination against Vancomycin-Resistant Enterococcus faecium. Antimicrobial Agents and Chemotherapy 42(10): 2564-2568, 1998

Modification of penicillin-binding protein 5 associated with high-level ampicillin resistance in Enterococcus faecium. Antimicrobial Agents and ChemoTherapy 40(2): 354-357, 1996

Entercoccus faecium with high-level resistance to gentamicin and ampicillin: an emerging clinical problem. Journal of Antimicrobial Chemotherapy 34(5): 846-847, 1994